Preliminaries

Détails

ID Serval
serval:BIB_72813A029A22
Type
Partie de livre
Sous-type
Chapitre: chapitre ou section
Collection
Publications
Institution
Titre
Preliminaries
Titre du livre
Successes and Limitations of Targeted Cancer Therapy
Auteur(s)
Stahel Rolf, Peters Solange
Editeur
S. KARGER AG
ISBN
9783318025415
9783318025422
ISSN
2296-1895
2296-1887
Statut éditorial
Publié
Date de publication
2014
Pages
I-VI
Langue
anglais
Résumé
The treatment of patients with advanced malignancies has undergone remarkable change in the last few years. While in the past decisions about systemic therapy were largely based on the performance status of a patient, oncologists today also take into account the pathological and molecular characteristics of the patient’s tumor. Targeting specific molecular pathways important for tumorigenesis has become the preferred way of treatment for many types of malignancies. With these advances come new challenges including the optimization of therapy, recognizing and dealing with side effects and, importantly, the development of resistance.
This book provides an up-to-date overview of the advances and limitations of targeted therapy for several tumor entities including breast cancer, colon cancer, gastrointestinal stromal tumors, lung cancer, melanoma, ovarian cancer and renal cell carcinoma. Written by over a dozen internationally renowned scientists, the book is suitable for advanced students, postdoctoral researchers, scientists and clinicians who wish to update their knowledge of the latest approaches to targeted cancer therapies.
Open Access
Oui
Création de la notice
09/02/2018 11:43
Dernière modification de la notice
21/11/2020 6:26
Données d'usage